Thurston, Springer, Miller, Herd & Titak, Inc. Assertio Holdings, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $558 Million
- Q1 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 67,500 shares of ASRT stock, worth $45,225. This represents 0.01% of its overall portfolio holdings.
Number of Shares
67,500
Previous 67,500
-0.0%
Holding current value
$45,225
Previous $58,000
18.97%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ASRT
# of Institutions
82Shares Held
27MCall Options Held
625KPut Options Held
136K-
Nantahala Capital Management, LLC New Canaan, CT8.44MShares$5.65 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$2.94 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.7MShares$1.81 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$928,7490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$742,1540.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $32.3M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...